As part of Emory School of Medicine’s commitment to advance bio innovation and entrepreneurship, Lab2Launch is designed to provide capital-efficient access to flexible coworking and wet laboratory space to Emory-affiliated companies developing promising technologies that ultimately improve patient health.

If you are a founder looking for wet lab space, please apply at https://bit.ly/lab2launchapp.

If you have any questions about the application process and Lab2Launch, visit our website.  in general, feel free to reach out to

For a quick reference of our offerings, please view/download our brochure.

Congratulations to David Weiss, PhD, co-PI of the Heteroresistance AST team, currently participating in the Biolocity Launch program. David Weiss, is the director of Emory’s Antibiotic Resistance Center and his team received a five-year $11 million grant from NIAID to continue their work in studying heteroresistance to treat bacterial infections.

Read More Here